Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein
Sara Lopes van den Broek(University of Copenhagen), Matthias M. Herth(University of Copenhagen), Guillermo Valenzuela(San Sebastián University), Constanza Salinas-Varas(Austral University of Chile), Alejandro Rojas‐Fernández(Austral University of Chile), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Ida Vang Andersen(University of Copenhagen), Daniel Watterson(The University of Queensland), Yorka Cheuquemilla(Austral University of Chile), David Schwefel(Humboldt-Universität zu Berlin), Umberto Maria Battisti(University of Copenhagen), Ronald Jara(Austral University of Chile), Naphak Modhiran(The University of Queensland), Vasko Kramer, Vladimir Shalgunov(University of Copenhagen), Rocío García‐Vázquez(University of Copenhagen)
Cited by 1
Related Papers
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177
Detection of dengue virus in saliva and urine by real time RT-PCR
|Virology Journal|2010|134